EN
HI
Summary
As of 1 Nov, 2026, Emcure Pharmaceuticals stock price is ₹1925.9. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Emcure Pharmaceuticals has traded between ₹1260.00 and ₹2048.00.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1925.90.
Emcure Pharmaceuticals has an upper circuit limit of ₹2058.90 and a lower circuit limit of ₹1684.70. The total value traded stands at ₹0.00, and the delivery percentage for the day is 53.02%.
The stock is currently traded with a market lot size of 1. Emcure Pharmaceuticals also offers a dividend yield of 0.19%.
Emcure Pharmaceuticals Share Price Chart
Emcure Pharmaceuticals Share Key Metrics
Volume
0.00
Market Cap
36568.62 CR
LTQ@LTP
5@1925.90
ATP
0
Var Margin
16.14 %
Circuit Range
1684.7-2058.9
Delivery %
53.02 %
Value
0.00
ASM/GSM
No
Market Lot
1
Emcure Pharmaceuticals Fundamentals
P/E Ratio
35.04
P/B Ratio
6.78
Div. Yield
0.19
Sector P/E
39.15
Sector P/B
3.25
Sec. Div. Yield
0.52
Emcure Pharmaceuticals Resistance and Support
Pivot 1865.83
Resistance
First Resistance
1885.36
Second Resistance
1905.73
Third Resistance
1925.26
Support
First Support
1845.46
Second Support
1825.93
Third Support
1805.56
Emcure Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 1858.1 | 1871.8 | 0.36% | 1887 | 1852.6 |
| Thu Oct 29 2026 | 1875 | 1865 | -0.53% | 1886.19 | 1846.3 |
| Wed Oct 28 2026 | 1875.69 | 1875 | -0.01% | 1889.19 | 1839.9 |
Emcure Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-03 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results & Final Dividend |
| 2026-02-04 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
Emcure Pharmaceuticals Management
| Name | Position |
|---|---|
| Berjis Desai | Chairman |
| Satish Mehta | Managing Director & Chief Executive Officer |
Emcure Pharmaceuticals Similar Stocks
Ipca Laboratories Ltd.
1965.00
38.80 (2.01%)
Anthem Biosciences Ltd.
933.35
103.20 (12.43%)
Ajanta Pharma Ltd.
3460.10
0.40 (0.01%)
Glaxosmithkline Pharmaceuticals Ltd.
2954.00
438.90 (17.45%)
Narayana Hrudayalaya Ltd.
1862.00
147.50 (8.60%)
Global Health Ltd.
1478.00
178.30 (13.72%)
Dr. Lal Pathlabs Ltd.
1895.00
-16.70 (0.87%)
Sai Life Sciences Ltd.
1584.90
89.20 (5.96%)
Wockhardt Ltd.
2088.70
165.80 (8.62%)
Emcure Pharmaceuticals FAQs
The Buying Price of Emcure Pharmaceuticals share is 1925.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emcure Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emcure Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emcure Pharmaceuticals shares is 35.04. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emcure Pharmaceuticals shares is 6.78. Useful to assess the stock's value relative to its book value.
To assess Emcure Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.15 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emcure Pharmaceuticals is 36568.62 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emcure Pharmaceuticals share price is 2048.00 & 1260.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emcure Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EMCURE
